Developer docs
API playgroundTry for free, no card

Search company profiles

Smartqare

Full company profile

uuid000ecm7

Namestring
Smartqare
Legal namestring
smartQare B.V.
Websiteurl
smartqare.nl
Company typeenum
Private
Founded yearint
2017
Descriptiontext

smartQare B.V. is a Dutch medical-technology company founded in 2017 and headquartered in Noordwijk (Eindhoven office at Strijp S), developing CE Class IIa-certified wearable remote patient monitoring (RPM) solutions. Its two core products — viQtor (an upper-arm multi-sensor wearable using PPG, accelerometer, gyroscope, barometer, and GNSS) and the Healthdot 3.1 chest biosensor — stream continuous vital signs (heart rate, respiratory rate, SpO2, skin temperature, activity, fall detection, location) directly to a cloud platform over LTE-M/NB-IoT or LoRa networks, eliminating the need for Bluetooth gateways, smartphones, or hospital Wi-Fi. Both devices are MDR Class IIa certified by Notified Body Kiwa Dare, and the company holds ISO 13485.

The platform targets hospitals, hospital-at-home/transitional care, and home care/district nursing organizations — specifically the monitoring gap between ICU continuous monitoring and intermittent ward spot-checks, including pre/post-operative patients, chronic disease patients (COPD, heart failure), and elderly living independently. SmartQare pursues enterprise field sales in the Netherlands and Europe alongside a strategic partnership signed with Royal Philips in January/April 2024, under which the integrated viQtor + Healthdot solution is co-sold globally (starting in Europe), with Philips retaining Legal Manufacturer status for Healthdot and providing HealthSuite Digital Platform (HSDP) hosting.

Revenue is generated through Class IIa medical device hardware sales, recurring cloud platform/dashboard subscriptions with EHR/EMR/ECD/EPD/HIS API integrations, and jointly delivered managed RPM services via Philips. Pricing is quote-based, tailored to enterprise contracts. The company has received an OpZuid EFRO R&D subsidy (June 2023), is part of the Brainport Eindhoven medtech ecosystem, and continues to scale Living Lab pilots with Sensire, NAAST-ZCN, Catharina Ziekenhuis, and LUMC into broader commercial deployments.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersEindhoven, Netherlands
HQ citystring
Eindhoven
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
remote patient monitoring, wearable medical devices, continuous vital sign monitoring, clinical decision support, connected health sensors
Industry3 codes
PRIMARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAJ
Medical Device Connectivity & Interoperability Middleware (MDI, EHR/HL7/FHIR Integration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Remote Patient Monitoring
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Wearable Medical Device Sales
TypeHardware Sales
Description

SmartQare generates revenue from the sale of its medical-grade wearable monitoring devices (viQtor and Healthdot 3.1). Both are certified Class IIa medical devices sold to healthcare organizations, hospitals, and home care providers.

smartqare.nl
2RPM Platform / Software Subscriptions
TypeSubscription Recurring
Description

The company offers a cloud-based monitoring platform and dashboards accessible to healthcare professionals. Data is transmitted from wearables directly to the platform, with alerts and trend analyses provided to care teams. The platform integrates with electronic health record systems (ECD/EPD/HIS) via APIs.

smartqare.nl
3Integrated RPM Solution (via Philips Partnership)
TypeManaged Services
Description

Following the 2024 Philips partnership, SmartQare combines viQtor and Healthdot RPM into one digital solution and platform, offered jointly by SmartQare and Philips to healthcare providers globally. Philips remains the legal manufacturer of Healthdot 3.1.

smartqare.nl
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1viQtor
Description

A wearable multisensor solution for 24-hour monitoring of vital signs including heart rate, oxygen saturation, skin temperature, activity, fall detection, and location. CE certified Class IIa medical device.

smartqare.nl
+1 more record
Core offering1 text field

SmartQare develops and sells medical-grade wearable biosensors (viQtor upper-arm multi-sensor and Healthdot 3.1 chest biosensor) combined with a cloud-based remote patient monitoring platform that delivers 24/7 continuous vital sign monitoring, fall detection, and clinical decision support to hospitals, hospital-at-home programs, and home care providers. Both devices are EU MDR Class IIa certified and transmit data directly to the cloud via cellular IoT (NB-IoT/LTE-M) and LoRa networks without requiring smartphones or gateways.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 62% reduction in manual nursing measurements per patient per day, saving approximately 10 minutes per patient per day
+5 more records
Product overview1 text field

Smartqare offers a comprehensive remote patient monitoring ecosystem consisting of two primary wearable devices: viQtor (upper arm-worn multi-sensor monitor) and Healthdot 3.1 (chest-worn biosensor). The viQtor solution includes the wearable device, cloud platform with dashboards, and mobile app for continuous vital signs monitoring. Healthdot 3.1 is designed for shorter-term monitoring during hospital-to-home transitions. Both devices feed data into the smartQare platform, which provides clinical decision support through continuous Early Warning Scores, trend analysis, and automated alerts. The company partnered with Philips in 2024 to integrate these solutions with Philips clinical software platforms.

Product and service3 records
1viQtor
CategoryRemote Patient Monitoring
Description

Upper-arm worn CE Class IIa medical device that continuously measures heart rate (30–240 bpm), respiratory rate (5–40 BRPM), SpO2 (70–100%), skin temperature (20–42.5°C), activity, and detects falls with GNSS location, transmitting data directly to the cloud over Vodafone NB-IoT/LTE-M with 5–7 day battery life. Sold to hospitals and home care organizations.

2Healthdot 3.1
CategoryRemote Patient Monitoring
Description

Lightweight (13.6g) IP55 splash-proof chest-worn CE Class IIa medical device that continuously monitors heart rate (30–220 bpm) and respiratory rate (5–60 rpm) using accelerometer-based technology, transmitting over LoRa networks with 14-day battery life for short-duration post-discharge and hospital-to-home transitions.

3smartQare Platform (Integrated RPM Platform)
CategoryClinical Monitoring Software
Description

Cloud-based integrated remote patient monitoring platform combining viQtor and Healthdot 3.1 device data with dashboards, continuous Early Warning Score (cEWS), trend analysis, configurable threshold alerts, and API integration to hospital EHR/EMR/ECD/EPD/HIS systems, co-sold with Philips to healthcare providers worldwide.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-04-04
Description

In April 2024 (formal announcement), Philips announced a strategic partnership to integrate SmartQare's technology with its clinical software platforms for patient monitoring. SmartQare combines its viQtor solution with Philips' Healthdot 3.1 into one digital RPM platform. Philips remains the legal manufacturer of Healthdot 3.1. The integrated solution is co-sold by both companies to healthcare providers globally, starting in Europe. Philips also provides access to its HealthSuite Digital Platform (HSDP) for secure data storage (EU/Ireland, ISO 27001, 27018, SOC II, HiTRUST).

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-11
Description

In January 2024 (initial signing), SmartQare and Philips signed a strategic partnership agreement in the presence of His Royal Highness Prince Constantijn van Oranje (Techleap.nl Special Envoy). SmartQare committed to merging viQtor and Healthdot RPM portfolios into one digital solution and platform, with Philips supporting global go-to-market. The transaction was expected to close in Q1 2024.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

LUMC, led by anesthesiologist Dr. Rutger van der Schrier, calibrated and validated viQtor's oxygen saturation measurements in late 2021. This clinical validation was a critical step toward CE Class IIa certification, providing independent medical institution endorsement of viQtor's SpO2 accuracy.

Strategic tierMinorTypeOthersAnnounced on2021-01-01
Description

Kiwa Dare is the Notified Body that audited SmartQare's quality management system and issued viQtor's CE Class IIa certification under EU MDR (EU) 2017/745. Kiwa Dare's 4-digit identification number (0404) appears on the CE marking.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Sensire, the largest home care organization in East Gelderland, was SmartQare's first Living Lab pilot partner. Clinicians used viQtor with real patients, providing feedback on clinical workflow integration, wear comfort, and monitoring outcomes. This pilot helped validate viQtor's practical utility and generated testimonials for clinical evidence.

6NAAST-ZCN
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

NAAST-ZCN is a medical service center (medisch service centrum) that partners with SmartQare and Sensire in Living Lab pilots. NAAST-ZCN provides 24/7 monitoring of clients, receives alerts from viQtor, and initiates protocol-driven actions (contacting clients, families, neighbors) before escalating to professional caregivers. Functions as the human monitoring tier in the care escalation protocol.

smartqare.nl
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Current Health provides a continuous vital-sign monitoring wearable and RPM platform for hospital-at-home and chronic care management, now part of Best Buy Health. Closely matches SmartQare's RPM+wearable+platform stack and target use cases.

TypeEmerging player
Description

iRhythm's Zio wearable patch provides continuous ambulatory cardiac monitoring with AI-based arrhythmia detection. Comparable technology category (medical-grade wearable biosensor with AI-driven clinical reporting) though focused on cardiac arrhythmia rather than multi-parameter vitals.

TypeBroad incumbent
Description

Masimo is a global medtech incumbent with patient-worn continuous monitoring (e.g., Radius PPG, SedLine) used in hospital and home settings. Comparable in technology category (continuous SpO2 and vitals) but competes as a broader portfolio vendor rather than an RPM-only specialist.

TypeBroad incumbent
Description

Medtronic runs remote cardiac monitoring (LINQ insertable cardiac monitor, connected CareLink) and broader hospital patient monitoring. Comparable on continuous vital-sign telemetry and remote data transmission into clinical platforms.

TypeBroad incumbent
Description

Royal Philips is SmartQare's strategic partner and runs its own RPM and patient monitoring portfolio (including the legacy Healthdot platform now transferred to SmartQare). Comparable because it competes and partners with SmartQare across the same continuous monitoring use cases and sells into the same European hospital channel.

TypeDirect peer
Description

Vivify Health offers an RPM platform with BYOD and kit options for chronic care, post-discharge, and population health. Comparable to SmartQare in RPM-as-a-service delivery for health systems and home care.

TypeBroad incumbent
Description

GE HealthCare offers continuous ward monitoring solutions (e.g., CARESCAPE, Mural) serving the same clinical workflow as viQtor in European and global hospitals. Comparable as a broad incumbent in patient monitoring adjacent to SmartQare's general-ward gap-target.

8Biofourmis
TypeDirect peer
Description

Biofourmis is a continuous RPM platform combining wearable biosensors with AI-driven analytics for hospital-at-home and post-discharge monitoring. Directly comparable to SmartQare's viQtor + Healthdot solution across care-setting coverage and clinical decision-support algorithms.

TypeEmerging player
Description

Huma operates a 'hospital-at-home' RPM platform combining device-agnostic data collection with predictive algorithms. Comparable as an emerging RPM platform competitor targeting the same European health systems and pharma-sponsored deployments.

TypeEmerging player
Description

VivaLnk makes medical-grade wearable patches and sensors (e.g., eSkin) used for continuous vitals monitoring and RPM integrations. Comparable as a connected medical-wearable vendor whose products compete for embedding into hospital RPM deployments.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Smartqare

Remote Patient Monitoringsmartqare.nl

What Smartqare does

smartQare B.V. is a Dutch medical-technology company founded in 2017 and headquartered in Noordwijk (Eindhoven office at Strijp S), developing CE Class IIa-certified wearable remote patient monitoring (RPM) solutions. Its two core products — viQtor (an upper-arm multi-sensor wearable using PPG, accelerometer, gyroscope, barometer, and GNSS) and the Healthdot 3.1 chest biosensor — stream continuous vital signs (heart rate, respiratory rate, SpO2, skin temperature, activity, fall detection, location) directly to a cloud platform over LTE-M/NB-IoT or LoRa networks, eliminating the need for Bluetooth gateways, smartphones, or hospital Wi-Fi. Both devices are MDR Class IIa certified by Notified Body Kiwa Dare, and the company holds ISO 13485.

The platform targets hospitals, hospital-at-home/transitional care, and home care/district nursing organizations — specifically the monitoring gap between ICU continuous monitoring and intermittent ward spot-checks, including pre/post-operative patients, chronic disease patients (COPD, heart failure), and elderly living independently. SmartQare pursues enterprise field sales in the Netherlands and Europe alongside a strategic partnership signed with Royal Philips in January/April 2024, under which the integrated viQtor + Healthdot solution is co-sold globally (starting in Europe), with Philips retaining Legal Manufacturer status for Healthdot and providing HealthSuite Digital Platform (HSDP) hosting.

Revenue is generated through Class IIa medical device hardware sales, recurring cloud platform/dashboard subscriptions with EHR/EMR/ECD/EPD/HIS API integrations, and jointly delivered managed RPM services via Philips. Pricing is quote-based, tailored to enterprise contracts. The company has received an OpZuid EFRO R&D subsidy (June 2023), is part of the Brainport Eindhoven medtech ecosystem, and continues to scale Living Lab pilots with Sensire, NAAST-ZCN, Catharina Ziekenhuis, and LUMC into broader commercial deployments.

Smartqare firmographics

Firmographics
Name
Smartqare
Legal name
smartQare B.V.
Website
https://smartqare.nl
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Smartqare industry classification

Industry
Product category
Remote Patient Monitoring
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAJ
Medical Device Connectivity & Interoperability Middleware (MDI, EHR/HL7/FHIR Integration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

Keywords

  • Remote patient monitoring
  • Wearable medical devices
  • Continuous vital sign monitoring
  • Clinical decision support
  • Connected health sensors

Where Smartqare is headquartered

Location

Headquarters

HQ city
Eindhoven
HQ country
Netherlands
HQ region
Europe

Offices2 records

Markets served

Smartqare business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Wearable Medical Device Sales: SmartQare generates revenue from the sale of its medical-grade wearable monitoring devices (viQtor and Healthdot 3.1). Both are certified Class IIa medical devices sold to healthcare organizations, hospitals, and home care providers.
  2. RPM Platform / Software Subscriptions: The company offers a cloud-based monitoring platform and dashboards accessible to healthcare professionals. Data is transmitted from wearables directly to the platform, with alerts and trend analyses provided to care teams. The platform integrates with electronic health record systems (ECD/EPD/HIS) via APIs.
  3. Integrated RPM Solution (via Philips Partnership): Following the 2024 Philips partnership, SmartQare combines viQtor and Healthdot RPM into one digital solution and platform, offered jointly by SmartQare and Philips to healthcare providers globally. Philips remains the legal manufacturer of Healthdot 3.1.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Smartqare product offering

Product offering

Core offering

SmartQare develops and sells medical-grade wearable biosensors (viQtor upper-arm multi-sensor and Healthdot 3.1 chest biosensor) combined with a cloud-based remote patient monitoring platform that delivers 24/7 continuous vital sign monitoring, fall detection, and clinical decision support to hospitals, hospital-at-home programs, and home care providers. Both devices are EU MDR Class IIa certified and transmit data directly to the cloud via cellular IoT (NB-IoT/LTE-M) and LoRa networks without requiring smartphones or gateways.

Product overview

Smartqare offers a comprehensive remote patient monitoring ecosystem consisting of two primary wearable devices: viQtor (upper arm-worn multi-sensor monitor) and Healthdot 3.1 (chest-worn biosensor). The viQtor solution includes the wearable device, cloud platform with dashboards, and mobile app for continuous vital signs monitoring. Healthdot 3.1 is designed for shorter-term monitoring during hospital-to-home transitions. Both devices feed data into the smartQare platform, which provides clinical decision support through continuous Early Warning Scores, trend analysis, and automated alerts. The company partnered with Philips in 2024 to integrate these solutions with Philips clinical software platforms.

Differentiator

Problem solved

Functional benefit

Brands

  • viQtor: A wearable multisensor solution for 24-hour monitoring of vital signs including heart rate, oxygen saturation, skin temperature, activity, fall detection, and location. CE certified Class IIa medical device.
  • Healthdot 3.1

Products and services

  • viQtor Upper-arm worn CE Class IIa medical device that continuously measures heart rate (30–240 bpm), respiratory rate (5–40 BRPM), SpO2 (70–100%), skin temperature (20–42.5°C), activity, and detects falls with GNSS location, transmitting data directly to the cloud over Vodafone NB-IoT/LTE-M with 5–7 day battery life. Sold to hospitals and home care organizations.
  • Healthdot 3.1 Lightweight (13.6g) IP55 splash-proof chest-worn CE Class IIa medical device that continuously monitors heart rate (30–220 bpm) and respiratory rate (5–60 rpm) using accelerometer-based technology, transmitting over LoRa networks with 14-day battery life for short-duration post-discharge and hospital-to-home transitions.
  • smartQare Platform (Integrated RPM Platform) Cloud-based integrated remote patient monitoring platform combining viQtor and Healthdot 3.1 device data with dashboards, continuous Early Warning Score (cEWS), trend analysis, configurable threshold alerts, and API integration to hospital EHR/EMR/ECD/EPD/HIS systems, co-sold with Philips to healthcare providers worldwide.

Quantifiable outcome

  • 62% reduction in manual nursing measurements per patient per day, saving approximately 10 minutes per patient per day
  • +5 more outcomes

Companies that use Smartqare

Customer profile

Named customers4 records

Segments5 records

Ideal customer profiles3 records

Smartqare technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability9 records

Feature6 records

Smartqare partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • Koninklijke Philips N.V. (Royal Philips)coreStrategic or Co-development Partner · 4 April 2024In April 2024 (formal announcement), Philips announced a strategic partnership to integrate SmartQare's technology with its clinical software platforms for patient monitoring. SmartQare combines its viQtor solution with Philips' Healthdot 3.1 into one digital RPM platform. Philips remains the legal manufacturer of Healthdot 3.1. The integrated solution is co-sold by both companies to healthcare providers globally, starting in Europe. Philips also provides access to its HealthSuite Digital Platform (HSDP) for secure data storage (EU/Ireland, ISO 27001, 27018, SOC II, HiTRUST).
  • Koninklijke Philips N.V. (Royal Philips)coreStrategic or Co-development Partner · 11 January 2024In January 2024 (initial signing), SmartQare and Philips signed a strategic partnership agreement in the presence of His Royal Highness Prince Constantijn van Oranje (Techleap.nl Special Envoy). SmartQare committed to merging viQtor and Healthdot RPM portfolios into one digital solution and platform, with Philips supporting global go-to-market. The transaction was expected to close in Q1 2024.
  • LUMC (Leids Universitair Medisch Centrum)minorStrategic or Co-development Partner · 1 January 2021LUMC, led by anesthesiologist Dr. Rutger van der Schrier, calibrated and validated viQtor's oxygen saturation measurements in late 2021. This clinical validation was a critical step toward CE Class IIa certification, providing independent medical institution endorsement of viQtor's SpO2 accuracy.
  • Kiwa Dare (Notified Body)minorOthers · 1 January 2021Kiwa Dare is the Notified Body that audited SmartQare's quality management system and issued viQtor's CE Class IIa certification under EU MDR (EU) 2017/745. Kiwa Dare's 4-digit identification number (0404) appears on the CE marking.
  • SensireminorStrategic or Co-development PartnerSensire, the largest home care organization in East Gelderland, was SmartQare's first Living Lab pilot partner. Clinicians used viQtor with real patients, providing feedback on clinical workflow integration, wear comfort, and monitoring outcomes. This pilot helped validate viQtor's practical utility and generated testimonials for clinical evidence.
  • NAAST-ZCNminorImplementation/ SI/ Consulting PartnerNAAST-ZCN is a medical service center (medisch service centrum) that partners with SmartQare and Sensire in Living Lab pilots. NAAST-ZCN provides 24/7 monitoring of clients, receives alerts from viQtor, and initiates protocol-driven actions (contacting clients, families, neighbors) before escalating to professional caregivers. Functions as the human monitoring tier in the care escalation protocol.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Smartqare competitors and assessment

Company assessment

Direct peers

  • Current Health (Best Buy Health): Current Health provides a continuous vital-sign monitoring wearable and RPM platform for hospital-at-home and chronic care management, now part of Best Buy Health. Closely matches SmartQare's RPM+wearable+platform stack and target use cases.
  • Vivify Health: Vivify Health offers an RPM platform with BYOD and kit options for chronic care, post-discharge, and population health. Comparable to SmartQare in RPM-as-a-service delivery for health systems and home care.
  • Biofourmis: Biofourmis is a continuous RPM platform combining wearable biosensors with AI-driven analytics for hospital-at-home and post-discharge monitoring. Directly comparable to SmartQare's viQtor + Healthdot solution across care-setting coverage and clinical decision-support algorithms.

Emerging players

  • iRhythm Technologies: iRhythm's Zio wearable patch provides continuous ambulatory cardiac monitoring with AI-based arrhythmia detection. Comparable technology category (medical-grade wearable biosensor with AI-driven clinical reporting) though focused on cardiac arrhythmia rather than multi-parameter vitals.
  • Huma (formerly Medopad): Huma operates a 'hospital-at-home' RPM platform combining device-agnostic data collection with predictive algorithms. Comparable as an emerging RPM platform competitor targeting the same European health systems and pharma-sponsored deployments.
  • VivaLnk: VivaLnk makes medical-grade wearable patches and sensors (e.g., eSkin) used for continuous vitals monitoring and RPM integrations. Comparable as a connected medical-wearable vendor whose products compete for embedding into hospital RPM deployments.

Broad incumbents

  • Masimo: Masimo is a global medtech incumbent with patient-worn continuous monitoring (e.g., Radius PPG, SedLine) used in hospital and home settings. Comparable in technology category (continuous SpO2 and vitals) but competes as a broader portfolio vendor rather than an RPM-only specialist.
  • Medtronic: Medtronic runs remote cardiac monitoring (LINQ insertable cardiac monitor, connected CareLink) and broader hospital patient monitoring. Comparable on continuous vital-sign telemetry and remote data transmission into clinical platforms.
  • Philips: Royal Philips is SmartQare's strategic partner and runs its own RPM and patient monitoring portfolio (including the legacy Healthdot platform now transferred to SmartQare). Comparable because it competes and partners with SmartQare across the same continuous monitoring use cases and sells into the same European hospital channel.
  • GE HealthCare: GE HealthCare offers continuous ward monitoring solutions (e.g., CARESCAPE, Mural) serving the same clinical workflow as viQtor in European and global hospitals. Comparable as a broad incumbent in patient monitoring adjacent to SmartQare's general-ward gap-target.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Smartqare social profiles

Digital presence

Smartqare compliance and trust

Trust signal

Compliance8 records

Smartqare financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Smartqare leadership team

Management profile

Number of profiles

Profiles10 records

Smartqare funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Smartqare M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Smartqare

What does Smartqare do?

SmartQare develops and sells medical-grade wearable biosensors (viQtor upper-arm multi-sensor and Healthdot 3.1 chest biosensor) combined with a cloud-based remote patient monitoring platform that delivers 24/7 continuous vital sign monitoring, fall detection, and clinical decision support to hospitals, hospital-at-home programs, and home care providers. Both devices are EU MDR Class IIa certified and transmit data directly to the cloud via cellular IoT (NB-IoT/LTE-M) and LoRa networks without requiring smartphones or gateways.

Is Smartqare a public or private company?

Smartqare is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Smartqare founded?

Smartqare was founded in 2017. It employs 11 to 50 people.

Where is Smartqare based?

Smartqare is headquartered in Eindhoven, Netherlands, in the Europe region.

How does Smartqare make money?

Three revenue lines are on record. Wearable Medical Device Sales are the primary driver. The others are RPM Platform / Software Subscriptions and integrated RPM Solution (via Philips Partnership).

Who are Smartqare's main competitors?

Direct peers on record are Current Health (Best Buy Health), Vivify Health and Biofourmis. Emerging players are iRhythm Technologies, Huma (formerly Medopad) and VivaLnk. Broad incumbents are Masimo, Medtronic, Philips and GE HealthCare.

Does Smartqare have an API?

Yes. The viQtor platform can be connected to electronic client and patient records (ECD/EPD/HIS) of healthcare providers via APIs. This integration allows all data to be directly available in the appropriate system.

What industry is Smartqare in?

Smartqare's product category is Remote Patient Monitoring. Its primary akta.pro industry code is HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MarketScreenerRoyal Philips, Blue Spark Technologies, Caretaker Medical, Cuviva, LifeSignals, Respiree And smartQare Expand Open Patient Monitoring Ecosystem To Help Health Systems Keep Sight Of Patients Beyond TheRoyal Philips announced new collaborations with Blue Spark Technologies, Caretaker Medical, Cuviva, LifeSignals, Respiree, and smartQare to expand its open patient monitoring ecosystem. These partnerships integrate wearable and out-of-hospital technologies into the Philips platform, enabling health systems to improve continuity of care from hospital to home through interoperable data integration.GlobeNewswirePhilips expands open patient monitoring ecosystem to help health systems keep sight of patients beyond the bedsidePhilips announced new collaborations with Blue Spark, Caretaker, Cuviva, LifeSignals, Respiree, and smartQare to expand its open monitoring ecosystem. The partnerships integrate wearable and out-of-hospital devices like temperature patches, blood pressure monitors, and cardio-respiratory biosensors into Philips' Patient Information Center iX. The goal is to support continuous patient monitoring from hospital to home.Mpo-magPhilips Expands its Open Patient Monitoring EcosystemPhilips announced new collaborations with Blue Spark, Caretaker, Cuviva, LifeSignals, Respiree, and smartQare to expand its open patient monitoring ecosystem. The partnerships integrate wearable and out-of-hospital technologies, including temperature, blood pressure, and cardio-respiratory monitoring, to support continuous care from hospital to home.openPR.comLeading Companies Fueling Innovation and Growth in the Artificial Intelligence (AI) in Remote Patient Monitoring MarketThe AI in remote patient monitoring market is projected to reach $8.02 billion by 2030, growing at a compound annual growth rate of 23.5%, driven by rising demand for home-based care and increasing investments in AI-powered healthcare analytics. Royal Philips partnered with SmartQare B.V. in April 2024 to enhance remote patient monitoring through advanced digital health technologies, aiming to improve patient outcomes and healthcare efficiency.openPR.comGlobal Factors Influencing the Rapid Evolution of the Home Health Monitoring Devices MarketThe home health monitoring devices market is projected to reach $1.83 billion by 2030, growing at a compound annual growth rate of 5.2%, driven by wearable technology innovations, an aging global population, increased telemedicine adoption, and investments in AI-powered health analytics. In April 2024, Royal Philips partnered with smartQare to combine clinical monitoring systems with SmartQare's viQtor solution for continuous patient monitoring in hospitals and remotely across Europe, while in July 2024 KORE, a US-based IoT company, released the mCareWatch 241 smartwatch featuring emergency SOS, GPS tracking, fall detection, and health monitoring capabilities.PhilipsAdvancing care from hospital to home: Our transitional care partnershipsPhilips announced partnerships with smartQare and Respiree to integrate wearable biosensor data into its patient monitoring ecosystem, enabling continuous vital sign monitoring for patients as they transition from hospital to home settings. The integrations allow clinicians to access real-time patient data through Philips monitoring platforms, supporting early detection of patient deterioration and reducing avoidable hospital readmissions. The article positions these partnerships as part of a broader healthcare industry shift toward connected care delivery models that extend clinical oversight beyond traditional hospital walls.openPR.comGrowth Patterns, Segment Analysis, and Competitive Approaches Influencing the Continuous Temperature Patch MarketThe continuous temperature patch market is forecast to reach $2.68 billion by 2030, growing at a compound annual growth rate of 13.7%, driven by rising remote patient monitoring adoption, wearable device usage, AI-powered alerts, and telehealth infrastructure expansion. In April 2024, Koninklijke Philips N.V. partnered with smartQare BV to integrate connected wearable biosensors with a digital platform for automated continuous patient monitoring in hospitals and home settings. Additionally, in January 2024, Blue Spark Technologies Inc. launched VitalTraq, a wearable temperature sensing product combined with contactless facial scanning for continuous vital sign monitoring.openPR.comEurope Telehealth & Telemedicine Market to Reach US$42.04 Billion by 2030The Europe telehealth and telemedicine market, valued at US$22.01 billion in 2024, is projected to grow at a CAGR of 11.2% to reach US$42.04 billion by 2030, driven by aging populations, rising chronic disease burden, and increasing adoption of remote consultations and AI-enabled diagnostics. Key growth enablers include expanding broadband connectivity and strong government support for digital health initiatives across European healthcare systems. Recent industry developments include Medtronic's FDA approval of a remote pacemaker monitoring app, Philips' partnership with smartQare for wearable biosensors, and Siemens Healthineers' 10-year partnership with OU Health for imaging and diagnostics.PhilipsPartnering with industry-leading companies to reduce complexity and improve efficiencyPhilips is partnering with industry-leading companies such as Masimo, Medtronic, and smartQare to integrate their measurement technologies and wearable biosensors into its IntelliVue patient monitoring systems. These collaborations aim to enhance clinical capabilities, improve operational efficiency, and advance vendor-neutral interoperability standards like Service-oriented Device Connectivity (SDC).Business InsiderPhilips (PHG) Boosts Patient Monitoring With SmartQare DealPhilips partnered with smartQare to integrate its viQtor patient monitoring solution into clinical platforms, and smartQare will acquire Philips' Healthdot business. The move aims to improve continuous monitoring and is expected to support Philips' Connected Care segment, with a market forecast of $38.95 billion by 2030.